Yasufumi Kaneda

Yasufumi Kaneda's AcademicInfluence.com Rankings

Yasufumi Kaneda

Biology

#7523

World Rank

#10460

Historical Rank

Molecular Biology

#873

World Rank

#896

Historical Rank

Biochemistry

#1039

World Rank

#1153

Historical Rank

biology Degrees

Download Badge

Biology

Yasufumi Kaneda's Degrees

PhD Pharmaceutical Sciences University of Tokyo
Masters Pharmaceutical Sciences University of Tokyo
Bachelors Pharmaceutical Sciences University of Tokyo

Why Is Yasufumi Kaneda Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yasufumi Kaneda's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (2000) (4240)
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. (1995) (786)
Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A* (2001) (645)
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction (1997) (637)
Hepatocyte growth factor gene therapy of liver cirrhosis in rats (1999) (610)
Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. (1993) (552)
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney (1996) (488)
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. (1995) (481)
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. (1993) (454)
Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue-derived Stromal Cells: P198 (2005) (412)
Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle (2002) (411)
Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. (2006) (376)
A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf–Hirschhorn syndrome (2009) (343)
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. (1994) (305)
Circulating Bone Marrow‐Derived Osteoblast Progenitor Cells Are Recruited to the Bone‐Forming Site by the CXCR4/Stromal Cell‐Derived Factor‐1 Pathway (2008) (267)
Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. (2002) (250)
Cell Transplantation for the Treatment of Acute Myocardial Infarction Using Vascular Endothelial Growth Factor–Expressing Skeletal Myoblasts (2001) (235)
Endothelial Apoptosis Induced by Oxidative Stress Through Activation of NF-&kgr;B: Antiapoptotic Effect of Antioxidant Agents on Endothelial Cells (2001) (234)
Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. (1999) (231)
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets (2000) (231)
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease (2001) (226)
Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. (1996) (219)
Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease (2004) (219)
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. (1994) (217)
Genetic engineering of vein grafts resistant to atherosclerosis. (1995) (216)
Essential Role for miR-196a in Brown Adipogenesis of White Fat Progenitor Cells (2012) (215)
PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia (2011) (215)
Overexpression of Interleukin-1 Receptor Antagonist Provides Cardioprotection Against Ischemia-Reperfusion Injury Associated With Reduction in Apoptosis (2001) (213)
Fusigenic viral liposome for gene therapy in cardiovascular diseases. (1996) (187)
ATP‐dependent chromatin remodeling facilitates nucleotide excision repair of UV‐induced DNA lesions in synthetic dinucleosomes (2001) (183)
Virosomes: evolution of the liposome as a targeted drug delivery system. (2000) (172)
Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model: Molecular Mechanisms of Delayed Angiogenesis in Diabetes (2001) (171)
Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. (2001) (168)
Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament (1998) (165)
Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo (2000) (160)
Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. (1997) (156)
Heat Shock Protein 72 Enhances Manganese Superoxide Dismutase Activity During Myocardial Ischemia-Reperfusion Injury, Associated With Mitochondrial Protection and Apoptosis Reduction (2002) (156)
Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. (1994) (155)
Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. (1999) (154)
Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction (2000) (154)
Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells (2001) (153)
Angiogenesis Induced by Endothelial Nitric Oxide Synthase Gene Through Vascular Endothelial Growth Factor Expression in a Rat Hindlimb Ischemia Model (2003) (150)
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. (1999) (149)
Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities (2003) (147)
[In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat]. (1997) (139)
A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. (1995) (135)
Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. (2007) (132)
Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin (2005) (131)
Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. (2007) (131)
Angiogenesis and Antifibrotic Action by Hepatocyte Growth Factor in Cardiomyopathy (2002) (127)
Gene Transfer of Dominant-Negative Mutants of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Prevents Neointimal Formation in Balloon-Injured Rat Artery (2001) (125)
Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. (2000) (124)
Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy (2001) (123)
Local Overexpression of Monocyte Chemoattractant Protein‐1 at Vessel Wall Induces Infiltration of Macrophages and Formation of Atherosclerotic Lesion: Synergism With Hypercholesterolemia (2002) (122)
Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. (1995) (121)
Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo (2002) (121)
Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. (2001) (119)
Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide (1997) (119)
Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. (2005) (117)
Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model (1999) (116)
Phase I/IIa Clinical Trial of Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer to Treat Critical Limb Ischemia (2011) (115)
Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling (2007) (114)
In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. (2000) (113)
Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. (2005) (113)
Periostin as a Novel Factor Responsible for Ventricular Dilation (2004) (111)
Direct in vivo gene introduction into rat kidney. (1992) (111)
Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model (2002) (110)
A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. (1997) (108)
In Vivo Evidence of Angiogenesis Induced by Transcription Factor Ets-1: Ets-1 Is Located Upstream of Angiogenesis Cascade (2004) (106)
Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin–dependent neointimal formation (1999) (106)
Gene Transfer of Human Prostacyclin Synthase Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats (2000) (104)
Selective inactivation of NF-κB in the liver using NF-κB decoy suppresses CCl4-induced liver injury and fibrosis (2007) (104)
Ribozyme Oligonucleotides Against Transforming Growth Factor-&bgr; Inhibited Neointimal Formation After Vascular Injury in Rat Model: Potential Application of Ribozyme Strategy to Treat Cardiovascular Disease (2000) (104)
Novel Therapeutic Strategy to Treat Brain Ischemia: Overexpression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury Without Cerebral Edema in Rat Model (2004) (104)
Novel and effective gene transfer technique for study of vascular renin angiotensin system. (1993) (103)
Gene therapy using HVJ-liposomes: the best of both worlds? (1999) (102)
Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. (2002) (100)
Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound (2004) (99)
Inhibition of Experimental Abdominal Aortic Aneurysm in the Rat by Use of Decoy Oligodeoxynucleotides Suppressing Activity of Nuclear Factor &kgr;B and ets Transcription Factors (2003) (98)
Angiogenic Property of Hepatocyte Growth Factor Is Dependent on Upregulation of Essential Transcription Factor for Angiogenesis, ets-1 (2003) (95)
Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. (1999) (93)
Linker histone variants control chromatin dynamics during early embryogenesis. (2005) (93)
Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. (2000) (92)
Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts (2003) (90)
Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis (2000) (90)
Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivo (2000) (89)
Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis (2006) (88)
Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. (2004) (88)
In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. (1997) (85)
Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice: Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene (2002) (85)
In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model (2000) (85)
Non‐viral vectors for cancer therapy (2006) (84)
Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma. (2014) (84)
Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. (1996) (82)
Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial Cells (2001) (81)
Genetic regulation of the RUNX transcription factor family has antitumor effects (2017) (80)
Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. (1999) (78)
CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells (2015) (78)
Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line. (2003) (77)
Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation (2007) (77)
Transient introduction of a foreign gene into healing rat patellar ligament. (1996) (76)
Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. (2008) (76)
Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. (2005) (76)
Inhibition of NFκB activation using cis-element ‘decoy’ of NFκB binding site reduces neointimal formation in porcine balloon-injured coronary artery model (2003) (75)
TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles (2012) (74)
Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. (1999) (74)
Efficient eradication of hormone‐resistant human prostate cancers by inactivated Sendai virus particle (2009) (74)
Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomes (1998) (74)
Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. (2002) (73)
Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. (1995) (73)
Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. (1994) (72)
cis Element Decoy Against Nuclear Factor-&kgr;B Attenuates Development of Experimental Autoimmune Myocarditis in Rats (2001) (72)
Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. (1998) (71)
Atherosclerosis and Angiogenesis: Its Pathophysiological Significance in Humans as Well as in an Animal Model Induced by the Gene Transfer of Vascular Endothelial Growth Factor a (1997) (71)
Amelioration of Pulmonary Emphysema by In Vivo Gene Transfection With Hepatocyte Growth Factor in Rats (2005) (70)
Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation (2006) (70)
Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons (2001) (70)
Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. (1995) (70)
Mouse model of human infertility: Transient and local inhibition of endometrial STAT‐3 activation results in implantation failure (2006) (68)
Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes (2000) (67)
Regression of Abdominal Aortic Aneurysms by Simultaneous Inhibition of Nuclear Factor &kgr;B and Ets in a Rabbit Model (2007) (66)
A comparison of in vivo gene delivery methods for antisense therapy in ligament healing (1998) (66)
Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70 (2000) (65)
Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. (2010) (65)
Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice. (2004) (65)
Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. (2006) (65)
Ubiquitin Carboxyl-Terminal Hydrolase L1, a Novel Deubiquitinating Enzyme in the Vasculature, Attenuates NF-&kgr;B Activation (2007) (64)
Gene Transfer of Hepatocyte Growth Factor Gene Improves Learning and Memory in the Chronic Stage of Cerebral Infarction (2006) (64)
Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site. (1998) (63)
Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation. (1996) (63)
Transplanted Bone Marrow–Derived Circulating PDGFRα+ Cells Restore Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Mouse Skin Graft (2015) (62)
Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. (2000) (62)
The Transcription Factors Tbx18 and Wt1 Control the Epicardial Epithelial-Mesenchymal Transition through Bi-Directional Regulation of Slug in Murine Primary Epicardial Cells (2013) (62)
Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene (2003) (62)
Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. (2007) (62)
Optimisation of the biology of soft tissue repair. (1999) (61)
Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts (2000) (61)
Nuclear factor κB decoy oligodeoxynucleotides prevent endotoxin‐induced fatal liver failure in a murine model (2003) (60)
Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. (2000) (60)
A long synthetic peptide containing a nuclear localization signal and its flanking sequences of SV40 T-antigen directs the transport of IgM into the nucleus efficiently. (1992) (60)
Gene Therapy for Attenuating Cardiac Allograft Arteriopathy Using Ex Vivo E2F Decoy Transfection by HVJ-AVE–Liposome Method in Mice and Nonhuman Primates (2000) (60)
Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model (2001) (59)
Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. (2009) (59)
Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. (1999) (59)
Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFκB and ets using chimeric decoy oligonucleotides in a rabbit model (2006) (58)
Histone methyltransferases: regulation of transcription and contribution to human disease (2010) (58)
Increased expression of DNA cointroduced with nuclear protein in adult rat liver (1995) (57)
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice (2001) (57)
Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. (2000) (57)
Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method. (1997) (56)
Long-Term Follow-Up Evaluation of Results From Clinical Trial Using Hepatocyte Growth Factor Gene to Treat Severe Peripheral Arterial Disease (2012) (56)
HVJ-envelope vector for gene transfer into central nervous system. (2003) (55)
In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. (1995) (55)
Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells (2001) (54)
LBP-p40 binds DNA tightly through associations with histones H2A, H2B, and H4. (1998) (54)
Lymphedema and Therapeutic Lymphangiogenesis (2013) (54)
Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome (1998) (54)
Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene (1998) (53)
Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40). (1996) (52)
Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase. (2000) (52)
Lamr1 functional retroposon causes right ventricular dysplasia in mice (2004) (52)
Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. (1993) (52)
Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ‐E) or type I interferon (2010) (52)
DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. (2006) (52)
Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy. (2010) (51)
Development of HVJ Envelope Vector and Its Application to Gene Therapy. (2005) (50)
Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. (2006) (50)
Virosome: a novel vector to enable multi-modal strategies for cancer therapy. (2012) (50)
Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles (2005) (50)
Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method. (2000) (50)
In vivo gene transfer into the retina mediated by a novel liposome system. (1996) (50)
Assembly of additional heterochromatin distinct from centromere-kinetochore chromatin is required for de novo formation of human artificial chromosome (2005) (49)
Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB. (2007) (49)
Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo (2004) (48)
Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα+ mesenchymal cells from bone marrow (2015) (48)
Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis. (1998) (48)
Title Glomerulosclerosis Induced by in vivo Transfection of transforming Growth Factor-β or Platelet-derived Growth Factor Gene into the Rat Kidney (48)
A case of Fabry's disease in a patient with no α‐galactosidase A activity caused by a single amino acid substitution of Pro‐40 by Ser (1990) (47)
Virus (Sendai Virus Envelopes)-Mediated Gene Transfer (1994) (47)
Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool (2010) (47)
Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest. (2001) (46)
Intrathecal injection of HVJ‐E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats (2004) (46)
ASGCT and JSGT Joint Position Statement on Human Genomic Editing. (2015) (46)
Gene Transfer of Hepatocyte Growth Factor to Subarachnoid Space in Cerebral Hypoperfusion Model (2002) (46)
Suppression of copulatory behavior by intracerebroventricular infusion of antisense oligodeoxynucleotide of granulin in neonatal male rats (2000) (45)
Dominant negative c-Jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats (2001) (45)
Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway (2014) (45)
In Vivo Gene Transfection With Hepatocyte Growth Factor via the Pulmonary Artery Induces Angiogenesis in the Rat Lung (2002) (45)
Enhanced Tumor-Specific Long-Term Immunity of Hemaggluttinating Virus of Japan-Mediated Dendritic Cell-Tumor Fused Cell Vaccination by Coadministration with CpG Oligodeoxynucleotides1 (2004) (45)
Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. (2000) (44)
Prevention of onset of Parkinson’s disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson’s disease (2006) (44)
Novel prophylactic and therapeutic vaccine against tuberculosis. (2009) (43)
Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma (2017) (43)
Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF‐κB‐dependent transcriptional control of α2,3‐sialyltransferase I, II, and VI in human castration‐resistant prostate cancer cells (2011) (42)
Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area (1997) (42)
In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat. (1997) (42)
Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia (2002) (41)
New vector innovation for drug delivery: development of fusigenic non-viral particles. (2003) (41)
Prevention of Restenosis by Gene Therapy (1997) (41)
Gene Transfer of the Serine Elastase Inhibitor Elafin Protects Against Vein Graft Degeneration (2000) (40)
Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system. (1996) (40)
Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. (2005) (40)
DNA methyltransferase 3b preferentially associates with condensed chromatin (2010) (40)
Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits (2004) (39)
Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts. (1999) (39)
Hypertension Accelerated Experimental Abdominal Aortic Aneurysm Through Upregulation of Nuclear Factor &kgr;B and Ets (2006) (39)
Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells. (2000) (39)
A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation. (2001) (39)
Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. (2002) (39)
Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases. (1999) (38)
Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin–conjugated HVJ envelope vector (2006) (38)
Hypertensive rats produced by in vivo introduction of the human renin gene. (1993) (38)
Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates. (2001) (38)
HIG1, a novel regulator of mitochondrial γ‐secretase, maintains normal mitochondrial function (2012) (38)
HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model (2002) (38)
Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma. (2002) (37)
Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population. (2010) (37)
TNF combined with IFN-α accelerates NF-κB-mediated apoptosis through enhancement of Fas expression in colon cancer cells (2003) (37)
Overexpressed heat shock protein 70 attenuates hypoxic injury in coronary endothelial cells. (1998) (36)
Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan). (2002) (36)
SF3B2-mediated RNA splicing drives human prostate cancer progression. (2019) (36)
Protective immunization against melanoma by gp100 DNA–HVJ-liposome vaccine (1999) (35)
Differential Regulation of Karyopherin α 2 Expression by TGF-β1 and IFN-γ in Normal Human Epidermal Keratinocytes: Evident Contribution of KPNA2 for Nuclear Translocation of IRF-1 (2007) (35)
Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells. (2008) (35)
[Direct in vivo gene introduction into rat kidney]. (1992) (34)
Alteration of the timing of implantation by in vivo gene transfer: delay of implantation by suppression of nuclear factor kappaB activity and partial rescue by leukemia inhibitory factor. (2004) (34)
Experimental bronchiolitis obliterans induced by in vivo HVJ-liposome-mediated endothelin-1 gene transfer. (1997) (34)
Low alpha-synuclein levels in the blood are associated with insulin resistance (2015) (34)
Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expression. (1998) (33)
Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. (2000) (33)
Microbubble-enhanced ultrasound for gene transfer into living skin equivalents. (2005) (33)
Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes (2007) (33)
Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with Shima Jet (2006) (32)
Highly efficient and minimally invasive in-vivo gene transfer to the mouse uterus using haemagglutinating virus of Japan (HVJ) envelope vector. (2003) (32)
Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1. (2007) (32)
Fusigenic liposome-mediated DNA transfer into cardiac myocytes. (1996) (32)
Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway (2013) (32)
TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells. (2003) (32)
Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine (1997) (32)
Inhibition of TNF-α, Induced Cytokine and Adhesion Molecule (2001) (32)
FHL-2 Suppresses VEGF-Induced Phosphatidylinositol 3-Kinase/Akt Activation via Interaction With Sphingosine Kinase-1 (2009) (32)
Gene therapy: a battle against biological barriers. (2001) (31)
Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. (2005) (31)
Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection. (2002) (31)
Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension (2007) (31)
Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1β mediated by a tumor-specific vector, HVJ cationic liposomes (2001) (31)
Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. (2003) (31)
In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method. (1997) (30)
A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkB binding site : Evidence for a role of NFkB in ischemia-reperfusion injury. Commentary (1997) (30)
Introduction of DNA into the rat and primate trabecular meshwork by fusogenic liposomes. (1998) (30)
Occurrence of free deaminoneuraminic acid (KDN)-containing complex-type N-glycans in human prostate cancers. (2013) (30)
Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins (2018) (30)
Molecular therapies for heritable blistering diseases. (2009) (30)
Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. (1996) (29)
Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve (2005) (29)
The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma (2011) (29)
Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition. (2001) (29)
The induction of apoptosis in HeLa cells by the loss of LBP-p40 (1998) (29)
Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc (2013) (29)
Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model (2005) (29)
Myocardial protection with endogenous overexpression of manganese superoxide dismutase. (1999) (29)
The Immediate Early Gene of Human Cytomegalovirus Stimulates Vascular Smooth Muscle Cell Proliferationin Vitroandin Vivo (1997) (29)
Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development. (2017) (29)
Widespread gene transfection into the central nervous system of primates (2000) (29)
Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo. (1999) (28)
Development of a novel antimicrobial peptide, AG-30, with angiogenic properties (2008) (28)
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells (2018) (28)
Genomic organization and promoter analysis of the Dnmt3b gene. (2003) (28)
Phosphorylation of p 38 Mitogen-Activated Protein Kinase Downstream of Bax-Caspase-3 Pathway Leads to Cell Death Induced by High D-Glucose in Human Endothelial Cells (2001) (28)
Molecular strategy using cis-element ‘decoy’ of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model (2002) (28)
In Vivo Gene Transfer of an Extracellular Domain of Platelet-Derived Growth Factor β Receptor by the HVJ-Liposome Method Ameliorates Bleomycin-Induced Pulmonary Fibrosis (1999) (28)
NFκB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts (2006) (28)
Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells (2012) (28)
Current status of gene therapy in Asia. (2008) (27)
The HVJ Liposome Method (1998) (26)
Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems (2008) (26)
Decoy Oligodeoxynucleotides As Novel Cardiovascular Drugs for Cardiovascular Disease (2001) (26)
Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats. (2009) (26)
Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity (2016) (26)
Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector. (2000) (25)
Histone H3 Lysine 36 Methyltransferase Whsc1 Promotes the Association of Runx2 and p300 in the Activation of Bone-Related Genes (2014) (25)
In vivo delivery of phosphorothioate oligonucleotides into murine retina. (1998) (25)
Development of a transferrin receptor-targeting HVJ-E vector. (2007) (25)
A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer. (2014) (25)
In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy. (2000) (25)
Targeted gene therapy for rat glomerulonephritis using HVJ‐immunoliposomes (2002) (25)
Gene therapy in vascular medicine: recent advances and future perspectives. (2001) (25)
A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma (2003) (25)
In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression. (1996) (25)
Ribosome-associated protein LBP/p40 binds to S21 protein of 40S ribosome: analysis using a yeast two-hybrid system. (1999) (24)
Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices. (2005) (24)
Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector (2005) (24)
Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis (2001) (24)
Efficient transfer of oligonucleotides and plasmid DNA into the whole heart through the coronary artery (1998) (24)
Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes. (2001) (24)
Nishikawa T, Du Edelstein DXL & Yamagishi S et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature404: 787-790 (2000) (24)
Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents (2012) (23)
Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma (2010) (23)
HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice (2001) (23)
Construction of a novel DNA decoy that inhibits the oncogenic β-catenin/T-cell factor pathway (2006) (23)
Virosome Presents Multimodel Cancer Therapy without Viral Replication (2013) (23)
Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope (2009) (22)
Novel therapeutic vaccine: Granulysin and new DNA vaccine against Tuberculosis (2011) (22)
Enhanced Therapeutic Angiogenesis by Cotransfection of Prostacyclin Synthase Gene or Optimization of Intramuscular Injection of Naked Plasmid DNA (2003) (22)
Efficient Transfer of Synthetic Ribozymes into Cells Using Hemagglutinating Virus of Japan (HVJ)-Cationic Liposomes (1997) (22)
Endogenous Mesenchymal Stromal Cells in Bone Marrow Are Required to Preserve Muscle Function in mdx Mice (2015) (22)
Hepatocyte growth factor as potential cardiovascular therapy (2005) (22)
Growth inhibition of cultured human Tenon's fibroblastic cells by targeting the E2F transcription factor. (1998) (22)
Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma (2010) (22)
Oncolytic Sendai virus-based virotherapy for cancer: recent advances (2015) (21)
Liposome-mediated gene transfer. (1995) (21)
Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma (1997) (20)
No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice. (2004) (20)
Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome. (1997) (20)
Variation in OSBPL10 is associated with dyslipidemia (2010) (20)
In vivo transfer of a beta 2-adrenergic receptor gene into the pressure-overloaded rat heart enhances cardiac response to beta-adrenergic agonist. (1998) (20)
Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases. (2003) (20)
Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy. (2000) (20)
Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector (2019) (20)
Introduction of a foreign gene into the kidney in vivo: development of glomerulosclerosis by the transfection of genes for PDGF and TGF-beta. (1994) (20)
Activation of the brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats. (1999) (19)
Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis (1999) (19)
Application of decoy oligodeoxynucleotides-based approach to renal diseases. (2004) (19)
Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models (2011) (19)
Induction of compensatory lung growth in pulmonary emphysema improves surgical outcomes in rats. (2005) (19)
NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis (2019) (19)
Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system. (1999) (19)
The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis (2013) (19)
Systemic Administration of a Novel Immune-Stimulatory Pseudovirion Suppresses Lung Metastatic Melanoma by Regionally Enhancing IFN-γ Production (2012) (19)
Mouse macrophage metalloelastase gene delivery by HVJ‐cationic liposomes in experimental antiangiogenic gene therapy for murine CT‐26 colon cancer (2001) (19)
New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin (2008) (18)
Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer (1997) (18)
Genetic modification of cold-preserved renal grafts using HSP70 or bcl-2 HVJ-liposome method. (2003) (18)
Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer. (2006) (18)
Localization-dependent cell-killing effects of protoporphyrin (PPIX)-lipid micelles and liposomes in photodynamic therapy. (2015) (18)
In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis. (1999) (18)
In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluid. (1996) (17)
Novel drug delivery system by surface modified magnetic nanoparticles. (2006) (17)
Chromosomal assignment of the gene for human elongation factor 2. (1984) (17)
Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus. (2004) (17)
Angiotensinogen gene-activating elements regulate blood pressure in the brain. (1999) (17)
Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy. (1993) (16)
Prevention of cardiac allograft arteriosclerosis using antisense proliferating-cell nuclear antigen oligonucleotide. (2000) (16)
Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin. (2007) (16)
Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients (2017) (16)
Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs? (2000) (16)
Improvements in gene therapy technologies. (2001) (16)
Gene transfer into the glomerulus by the hemagglutinating virus of Japan-liposome method. (1997) (16)
The effect of VEGF on blood vessels and blood cells during Xenopus development. (2006) (16)
HVJ-based non-viral gene transfer method: successful gene therapy using HGF and VEGF genes in experimental ischemia. (2006) (16)
Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development (2016) (16)
Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma (2011) (16)
Effect of angiotensinogen on blood pressure regulation in normotensive rats: application of a loss of function approach (1995) (16)
Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides. (2004) (15)
Transluminal Gene Transfer into Brain Capillary Endothelial Cells In Vivo with HVJ-liposomes (2002) (15)
Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application (2013) (15)
E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis. (2006) (15)
HVJ-liposome mediated gene transfer into hepatocytes in vivo. (1998) (15)
Functional modification of Sendai virus by siRNA. (2008) (14)
Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome. (1998) (14)
Longitudinal Single-Cell Transcriptomics Reveals a Role for Serpina3n-Mediated Resolution of Inflammation in a Mouse Colitis Model (2021) (14)
Mallotus philippinensis bark extracts promote preferential migration of mesenchymal stem cells and improve wound healing in mice. (2014) (14)
A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy (2007) (14)
Efficient Introduction of Macromolecules and Oligonucleotides into Brain Capillary Endothelial Cells Using HVJ-Liposomes (2000) (14)
The analysis of 40 kDa nuclear protein, p40, in interphase cells and mitotic cells. (1993) (14)
Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy (2005) (14)
Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase (2001) (14)
EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy (2001) (14)
Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB. (2001) (14)
The analysis of 40 kDa nuclear protein, p40, in interphase cells and mitotic cells. (1993) (14)
Transposon-independent increase of transcription by the Sleeping Beauty transposase. (2004) (13)
Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis (2011) (13)
Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector (2007) (13)
Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice. (2014) (13)
Gene transfer to the rat biliary tract with the HVJ-cationic liposome method. (1999) (13)
Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene (2002) (13)
Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide (2006) (13)
Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study (2020) (13)
Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma. (2013) (13)
Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter (2006) (13)
Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. (2004) (12)
Simple and highly efficient method for transient in vivo gene transfer to mid-late pregnant mouse uterus. (2006) (12)
Efficient gene transfer from innervated muscle into rat peripheral and central nervous systems using a non‐viral haemagglutinating virus of Japan (HVJ)‐liposome method (2003) (12)
Critical roles of cold shock domain protein A as an endogenous angiogenesis inhibitor in skeletal muscle. (2011) (12)
Antisense in vivo knockdown of synaptotagmin I and synapsin I by HVJ-liposome mediated gene transfer modulates ischemic injury of hippocampus in opposing ways (2003) (12)
Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice (2015) (12)
Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector. (2006) (12)
13‐Cis retinoic acid can enhance the antitumor activity of non‐replicating Sendai virus particle against neuroblastoma (2013) (12)
A novel gene-transfer technique mediated by HVJ (Sendai virus), nuclear protein, and liposomes. (1994) (12)
Development of boron nanocapsules for neutron capture therapy. (2009) (12)
Effective transfection of a cis element “decoy” of the nuclear factor-?B binding site into the experimental choroidal neovascularization (2002) (11)
Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo (2011) (11)
An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis. (2016) (11)
Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. (2004) (11)
Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice. (2016) (11)
Antisense Cdk2 kinase oligodeoxynucleotide inhibits ICAM-1 expression in murine cardiac allograft arteriopathy. (1998) (11)
N141I mutant presenilin-2 gene enhances neuronal cell death and decreases bcl-2 expression. (2002) (11)
Wild‐Type p53 Gene Transfer: A Novel Therapeutic Strategy for Neointimal Hyperplasia after Arterial Injury a (1997) (11)
Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis (2007) (11)
Reconstituted fusion liposomes for gene transfer in vitro and in vivo (2000) (11)
Reconstitution of chromatin in vitro. (2001) (10)
Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element (2008) (10)
A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines (2020) (10)
The HVJ-envelope as an innovative vector system for cardiovascular disease. (2004) (10)
Ribosomal proteins S0 and S21 are involved in the stability of 18S rRNA in fission yeast, Schizosaccharomyces pombe. (2003) (10)
Sendai virus F glycoprotein induces IL‐6 production in dendritic cells in a fusion‐independent manner (2008) (10)
Egr-1 in vascular smooth muscle cell proliferation in response to allo-antigen. (2003) (10)
Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein(a) gene. (1998) (10)
Gene therapy for ischemic brain diseases. (2003) (10)
Gene transfection of beta 2-adrenergic receptor into the normal rat heart enhances cardiac response to beta-adrenergic agonist. (1999) (10)
Involvement of γ-secretase in postnatal angiogenesis (2007) (9)
Gene Therapy for Cardiovascular Disease Using Hepatocyte Growth Factor (2000) (9)
Development of liposomes and pseudovirions with fusion activity for efficient gene delivery. (2011) (9)
A non-replicating oncolytic vector as a novel therapeutic tool against cancer. (2010) (9)
Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys. (2002) (9)
Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane. (2017) (9)
Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats. (2008) (9)
Gene Therapy for Heart Transplantation‐Associated Coronary Arteriosclerosis a (2000) (9)
Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation (2016) (9)
Involvement of gamma-secretase in postnatal angiogenesis. (2007) (9)
The Efficacy and Safety of Gene Transfer into the Porcine Liver In Vivo by HVJ (Sendai Virus) Liposome (2005) (9)
Hepatocyte growth factor gene therapy reduces ventricular arrhythmia in animal models of myocardial ischemia. (2005) (9)
Synaptotagmin I hypothalamic knockdown prevents amygdaloid seizure-induced damage of hippocampal neurons but not of entorhinal neurons (2002) (8)
Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene (2016) (8)
Safe and efficient gene transfer into porcine hepatocytes using Sendai virus-cationic liposomes for bioartificial liver support. (2000) (8)
Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment. (2020) (8)
Effect on vein graft intimal hyperplasia of nuclear factor-kB decoy transfection using the second generation of HVJ vector. (2007) (8)
In vivo gene transfer into the mouse uterus: a powerful tool for investigating implantation physiology. (2005) (8)
Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule‐1 and enhances natural killer cell sensitivity on cancer cells (2017) (8)
Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase. (1998) (8)
Cutaneous gene delivery. (2008) (8)
Introduction and expression of human CD59 gene in the canine kidney. (1994) (8)
Gene transfer and kidney disease. (1998) (8)
Gene transfer to vein graft wall by HVJ-liposome method: time course and localization of gene expression. (1998) (8)
Transfection of Antisense p 53 Tumor Suppressor Gene Oligodeoxynucleotides Into Rat Carotid Artery Results in Abnormal Growth of Vascular Smooth Muscle Cells (2000) (7)
Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles. (2019) (7)
Novel strategy of gene therapy in cardiovascular disease with HVJ-liposome method. (1996) (7)
A Novel Therapy for Melanoma and Prostate Cancer Using a Non-Replicating Sendai Virus Particle (HVJ-E) (2013) (7)
Cytoprotection by bcl‐2 gene transfer against ischemic liver injuries together with repressed lipid peroxidation and increased ascorbic acid in livers and serum (2004) (7)
[Gene therapy of cardiovascular disorders]. (1999) (7)
Somatic gene targeting with RNA/DNA chimeric oligonucleotides: an analysis with a sensitive reporter mouse system (2004) (7)
Biological Barriers to Gene Transfer (2004) (7)
Tumor necrosis factor‐a antisense transfer remarkably improves hepatic graft viability (2006) (7)
Ecto-5'-nucleotidase plays a role in the cardioprotective effects of heat shock protein 72 in ischemia-reperfusion injury in rat hearts. (2000) (7)
Methyl-beta cyclodextrin alters the production and infectivity of Sendai virus (2011) (6)
Human Cytomegalovirus Immediate-Early Protein IE2–86, but not IE1–72, Causes Graft Coronary Arteriopathy in the Transplanted Rat Heart (2002) (6)
Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer (2020) (6)
Application of antisense oligodeoxynucleotides (ODNs) for the intervention of kidney disease. Antisense ODNs for transforming growth factor-beta-suppressed glomerulosclerosis in experimental glomerulonephritis. (1996) (6)
Design and synthesis of a phenyl C-glycoside derivative of Spliceostatin A and its biological evaluation toward prostate cancer treatment (2019) (6)
Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. (2005) (6)
Physician‐initiated first‐in‐human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers (2017) (6)
Gene Transfer of Prostaglandin Synthase Maintains Patency of the Newborn Lamb Arterial Duct (2005) (6)
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy (2020) (6)
Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during mid-term pregnancy lowers systemic maternal blood pressure. (2006) (5)
Regional assignment of five genes on human chromosome 19 (2004) (5)
The hemagglutinating virus of Japan-liposome method for gene delivery. (2003) (5)
Fusigenic sendai-virus liposomes : a novel hybrid type liposome for gene therapy (1998) (5)
Injection of HGF Plasmid cDNA to Prevent Manifestation of Parkinson Disease: A Preclinical Study using a Primate Model (2009) (5)
Hemagglutinating Virus of Japan Envelope Vectors as High-Performance Vehicles for Delivery of Small RNAs (2013) (5)
Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth (2017) (5)
E2F decoy suppresses E-selectin expression in murine cardiac allograft arteriopathy. (1999) (5)
Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide. (2006) (5)
LBP-p 40 Binds DNA Tightly through Associations with Histones (1998) (5)
Subcellular trafficking of exogenously expressed interferon‐β in Madin–Darby canine kidney cells (2004) (5)
HVJ liposomes and HVJ envelope vectors. (2011) (4)
DNA vaccines for cancer treatment. (2001) (4)
Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing (2015) (4)
Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy. (2007) (4)
Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies. (2002) (4)
Transfection of the anti-apoptotic gene bcl-2 inhibits oxidative stress-induced cell injuries through delaying of NF-!B activation (2006) (4)
Lack of association between the hepatocyte growth factor receptor, c-met, and the anti-apoptotic action of bag-1 in endothelial cells. (2004) (4)
In vivo transfer of a β2-Adrenergic receptor gene into the pressure-overloaded rat heart enhances cardiac response to β-adrenergic agonist. Commentary (1998) (4)
Identification and significance of pyrochlorins in fecal pellets of the marine malacostracan crustaceans Heptacarpus rectirostris and Palaemon pacificus (1993) (4)
Changes in Pulmonary Histology and Exfoliated Bronchoalveolar Cells Induced by In Vivo Introduction of the Tumor Necrosis Factor-α Gene (2000) (4)
Catheter-delivered in vivo gene transfer into rat myocardium using the fusigenic liposomal mediated method. (2000) (4)
Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse. (2002) (4)
Downregulation of nuclear factor kappa B expression in primate cardiac allograft arteries after E2F decoy transfection. (2001) (4)
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. (2012) (4)
Regional assignment of the gene for diphtheria toxin sensitivity using subchromosomal fragments in microcell hybrids (2004) (4)
Development of Laser Ionization Techniques for Evaluation of the Effect of Cancer Drugs Using Imaging Mass Spectrometry (2014) (4)
Suppression of oxidative stress-induced hepatocyte injury by calpain antisense. (2003) (4)
The effect of gene transfer with hepatocyte growth factor for pulmonary vascular hypoplasia in neonatal porcine model. (2005) (3)
In vivo gene transfer into choroidal neovascularization by the HVJ liposome method (2000) (3)
Therapeutic strategies for controlling the metastasis and recurrence of cancers: contribution of drug delivery technologies. (2012) (3)
Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma (2020) (3)
Gene therapy as a potential treatment for restenosis and myocardial infarction. (2000) (3)
Intratumoral and subcutaneous injection of HVJ-E (GEN0101) in metastatic castration-resistant prostate cancer. (2020) (3)
[Gene transfer with ultrasound and microbubbles (optison) as a potential treatment for cardiovascular diseases]. (2004) (3)
Gene therapy of ischemic-damaged kidney in the rat using hepatocyte growth factor gene. (2001) (3)
179 Systemic administration of HMGB1 peptide drastically improves survival of the RDEB model mice by mobilizing multipotent stem/progenitor cells from bone marrow (2017) (3)
Therapeutic Potential of Oligonucleotide-Based Therapy in Cardiovascular Disease (2012) (3)
Current status and future prospects of gene therapy technologies toward the treatment of intractable skin diseases (2003) (3)
Cut-C: cleavage under tethered nuclease for conformational capture (2019) (3)
Hemagglutinating virus of Japan-artificial viral envelope liposome-mediated cotransfer of bag-1 and bcl-2 genes protects hepatic cells against ischemic injury through BAG-1-assisted preferential enhancement of bcl-2 protein expression. (2005) (3)
A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma (2022) (3)
Hemagglutinating virus of Japan envelope (HVJ-E) allows targeted and efficient delivery of photosensitizer for photodynamic therapy against advanced prostate cancer (2015) (3)
[Anticancer immunotherapy using inactivated Sendai virus particles]. (2007) (3)
[NFkappaB decoy DNA for treatment of atopic dermatitis]. (2005) (2)
906 Systemic HMGB1 administration ameliorates cutaneous and non-cutaneous manifestations in a dystrophic epidermolysis bullosa model mouse (2017) (2)
Prevention of cardiac allograft arteriopathy by antisense Cdc2 kinase oligonucleotide. (1999) (2)
Photodynamic therapy using hemagglutinating virus of Japan envelope (HVJ-E): a novel therapeutic approach for the treatment of hormone antagonistic prostate cancer (2015) (2)
Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)-liposome method in rats. (2006) (2)
HVJ-E containing PD-L1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma. (2020) (2)
843 Systemic delivery of HMGB1 promotes tissue regeneration by activating PDGFRα cells in a mouse model of epidermolysis bullosa (2018) (2)
HVJ (hemagglutinating virus of Japan; Sendai virus)-liposome method. (2002) (2)
P1.14-19 Hemagglutinating Virus of Japan Envelope (HVJ-E: Inactivated Viral Nanoparticles) Against Chemotherapy-Resistant Pleural Mesothelioma (2018) (2)
Prevention and regression of atopic dermatitis by ointment containing NFkB decoy oligodeoxynucleotides in NC/Nga atopic mice model (2002) (2)
Tissue regeneration by recruitment of stem cells to injured tissues (2012) (2)
Potential gene therapy for glomerulonephritis: Transfection of NFKB decoy inhibited TNF-A induced cytokine and adhesion molecules expression in vivo (1996) (2)
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens (2020) (2)
Gene Therapy of Melanoma Using Inactivated Sendai Virus Envelope Vector (HVJ-E) with Intrinsic Anti-Tumor Activities (2011) (2)
Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: role of lipoprotein (a) in renal disease. (1998) (2)
Highly Selective Photodynamic Therapy with a Short Drug-Light Interval Using a Cytotoxic Photosensitizer Porphyrus Envelope for Drug-Resistant Prostate Cancer Cells (2018) (2)
The loss of 40-kDa chromosomal protein in tuberous sclerosis lesions. (1995) (2)
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model (2010) (2)
Therapeutic angiogenesis induced by HGF: Potential gene therapy for ischemic diseases (2000) (2)
Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway (2012) (1)
Nuclear Pore Complex (2011) (1)
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. (2012) (1)
Nonviral HVJ (Hemagglutinating Virus of Japan) Liposome-Mediated Retrograde Gene Transfer of Human Hypatocyte Growth Factor in the Rat Nervous System Promotes Functional and Histological Recovery of Crushed Nerve (2006) (1)
Enhancement of Ionization Efficiency Using Zeolite in Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry of Multiple Drugs in Cancer Cells (Mass Spectrometry of Multiple Drugs in Cells Using Zeolite) (2020) (1)
Effects of gene transfection of human bcl-2 on concordant cardiac xenografts in hamster to rat model. (2001) (1)
IS028 GENE THERAPY OF RESTENOSIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) THROUGH THE ACCELATION OF RE-ENDOTHELIALIZATION (1998) (1)
Intratumoral and subcutaneous injection of HVJ-E (GEN0101) for metastatic castration-resistant prostate cancer: Open-label, phase I, dose escalation study. (2019) (1)
Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication). (2016) (1)
[Development of in vivo gene transfer methods towards future gene therapy]. (1997) (1)
Novel pathophysiological roles of α‐synuclein in age‐related vascular endothelial dysfunction (2022) (1)
Antisense Cdc2 kinase oligonucleotide inhibits adhesion molecule expression in cardiac allograft arteriopathy. (1999) (1)
Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium (2020) (1)
Regulation of HN activity of HVJ with HN specific siRNA (2006) (1)
Mitogenic and Anti-Apoptotic Actions of Hepatocyte Growth Factor Through Erk, Stat3 and Akt in Human Aortic Endothelial Cells (2000) (1)
[Progress of human gene therapy]. (2009) (1)
1.P.118 Novel gene therapy strategy for atherosclerosis using ribozyme against apolipoprotein (a) gene (1997) (1)
Development of HVJ envelope vector and its application to gene therapy. (2005) (1)
Open-label, phase I, dose escalation study to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E (GEN0101) in castration-resistant prostate cancer patients (2019) (1)
Novel High Efficiency Gene transfer Technique into neonatal cardiac myocyte : Second Generation of HVJ vector (HVJ-envelope) (2002) (1)
Author response: Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development (2016) (1)
Peroxisomal Membrane Protein PMP34 Is Involved in the Human Papillomavirus Infection Pathway (2022) (1)
Sustained transgene expression by transfection of renin gene into liver of neonates. (1996) (1)
OE-328 Increase in DNA Synthesis of Cardiomyocytes by Transfection of Antisense p53 and Rb Oligodeoxynucleotides : Possibility of Regeneration of Cardiomyocytes(Gene Therapy 2 (IHD) : OE41)(Oral Presentation (English)) (2004) (1)
279. Eradication of Renal Cell Carcinoma in Mice Mediated by NK Cell Activation Using Inactivated Sendai Virus Particle (HVJ-E) (2006) (1)
[Development of virosome-mediated cancer therapy]. (2016) (1)
HVJ-Liposome-Mediated Gene Transfer to Healing Rat Meniscal Tissue* (2000) (1)
Monoclonal antibodies specific for human chromosome 5 obtained with a monochromosomal hybrid can be used to sort out cells containing the chromosome with a FACS (1991) (1)
Development of LC-MS/MS Quantification of the Novel Antimicrobial Peptide, SR-0379, and its Pharmacokinetics in Rats (2014) (1)
[Gene therapy: current status and promise]. (2001) (1)
[Current status of human gene therapy]. (2002) (1)
Development of non-viral gene delivery system (2002) (1)
Cancer immunotherapy using the Fusion gene of Sendai virus (2019) (1)
Construction of radiation-reduced hybrids and their use in mapping of microclones from chromosome 10p11.2-q11.2 (1993) (1)
Nanotechnology for Gene Therapy – HVJ‐E Vector (2007) (1)
Future directions for gene therapy (2013) (1)
480 EXPRESSION OF GANGLIOSIDES, GD1A AND SIALYL PARAGLOBOSIDE, IS REGULATED BY NF-κB-DEPENDENT TRANSCRIPTIONAL CONTROL OF α2,3-SIALYLTRANSFERASE I, II AND VI IN HUMAN CASTRATION-RESISTANT PROSTATE CANCER CELLS (2012) (0)
Immunofluorescence Analysis of Cultured Mammalian Cell Nucleus Using Four Monoclonal Antibodies against the Nucleus (1987) (0)
Functional Analysis of Cis-element and Bindibng Protein as Regulators of Angiotensinogen Generation in SHR (1998) (0)
[Future view of gene therapy in cardiovascular field]. (2005) (0)
Identification of angiogenic and antimicrobial factor, AG-30, and analysis of its De Novo engineered variants (2008) (0)
1845: Efficient Ultrasound-Mediated Gene Transfer of Nfkb Decoy Into Donor Kidneysprolonged Survival of rat Renal Allografts (2004) (0)
Ng atopic dermatitis (2002) (0)
Efficient Transfer of Oligonucleotide and Plasmid DNA into Whole Heart Through Coronary Artery (1996) (0)
, Activating Elements Regulate Blood Pressure in the Brain − Angiotensinogen Gene (1999) (0)
VEGF (164) INDUCES TRANSFORMATION OF BLOOD CELLS PRECURSORS INTO ENDOTHEUAL CELLS IN DEVELOPING POSTERIOR BLOOD ISLAND: P 235 (2004) (0)
ULTRASOUND-MEDIATED NONVIRAL EX VIVO GENE TRANSFER INTO LIVER GRAFT (2004) (0)
Immunity to mycobacterial infection (WS-061) Chairpersons: Kiyoshi Takatsu, Masaji Okada (2010) (0)
Using Hepatocyte Growth Factor Gene to Treat Severe Peripheral Arterial Disease (0)
Novel Therapeutic Approaches against Experimental Pulmonary Hypertension by Targeting Endothelial Cell-Related Signaling Pathways and Regeneration (2003) (0)
Potential of Transcription Factor Decoy Oligonucleotides as Therapeutic Approach (2004) (0)
Gene Therapy for Myocardial Infarction: A Real Medicine in the Next Millenium? (2000) (0)
Evolution of Viral Liposomes: Improvements and Applications (2001) (0)
DEVELOPMENT OF HVJ-LIPOSOMES AND CANCER GENE THERAPY (2001) (0)
Acceleration of neointimal hyperplasia in Lp(a) transgenic mice : Contribution of Lp(a) in the pathogenesis of vascular disease (2002) (0)
Inhibition of the growth of vascular smooth muscle cells by antisense oligonucleotides (1995) (0)
3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Transcriptionally distinct mesenchymal stem/stromal cells circulate in fetus. (2019) (0)
-0501-PROLIFERATION OF CARDIOMYOCYTES TRANSFORMED WITH SV 40 T ANTIGEN GENE (1990) (0)
Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model (2003) (0)
452. The Enhancement of Anticancer Effect of Chemotherapy by the Delivery of Rad51 siRNA (2005) (0)
Hepatocyte growth factor specifies hemotopoitic mesoderm in Xenopus embryos (2002) (0)
NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis (2019) (0)
Diabetes Diabetic Hind Limb Ischemia Model : Molecular Mechanisms of Delayed Angiogenesis in Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat (2001) (0)
, Hypoperfusion Model Gene Transfer of Hepatocyte Growth Factor to Subarachnoid Space in Cerebral (2002) (0)
FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (English)) (2004) (0)
Basic investigation of boron neutron capture therapy (BNCT) using novel boron agents and accelerator based neutron source (2009) (0)
Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing (2022) (0)
NF-κB decoy prevents the progression of anti-GBM glomerulonephritis in rats (1999) (0)
Cancer immunotherapy using the Fusion gene of Sendai virus (2019) (0)
671 Comprehensive analysis on HMGB1-induced circulating cells during cutaneous tissue regeneration (2017) (0)
Erratum: Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector Saroj Suvanasuthi, Katsuto Tamai, Yasufumi Kaneda. Journal of gene medicine, 2007; 9: 55–62 (2007) (0)
TOPICAL APPLICATION OF A NF-kB decoy FOR TREATING ATOPIC DERMATITIS (2002) (0)
Present and Future in the genetherapy for cardiovascnlardisease (1999) (0)
Therapeutic strategies for controlling metastasis and recurrence of cancers (2010) (0)
Development and application of DDS to activate anti-tumor immunity (2017) (0)
Delivery of siRNA using HVJ envelope vector (2004) (0)
Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study (2023) (0)
Prevention of Restenosis After Angioplasty: Efficacy of Antisense Strategy Against Cell Cycle Regulatory Genes: ―アンチセンス技術の応用と遺伝子導入― (1995) (0)
Gene Therapy to Treat Diabetic Neuropathy : Improvement of Diabetic Peripheral Neuropathy by HGF Gene and Prostacyclin Synthase Gene Transfer (2003) (0)
STATINS ATTENUATE CARDIAC HYPERTROPHY THROUGH INHIBITION OF NOX2-CONTAINING NADPH OXIDASE: OP 115 (2004) (0)
Long-Term Follow-Up Evaluation of Results From Clinical Trial ( TREAT-HGF ) Using Hepatocyte Growth Factor Gene to Treat Severe Peripheral Arterial Disease (2012) (0)
IS033 UP-REGULATION OF KEY TRANSCRIPTIONAL FACTOR FOR ANGIOGENESIS, ETS, AND INDUCTION OF ANGIOGENESIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) INTO MYOCARDIUM (1998) (0)
Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins (2018) (0)
Antisense oligonucleotide-induced suppression of calpain μ expression prevents oxidative stress-induced hepatocyte injury (1998) (0)
Epidermolysis Bullosa Mouse Skin Graft VII Collagen in Recessive Dystrophic Cells Restore Type + a Circulating PDGFR Derived - Transplanted Bone Marrow (2015) (0)
Application of NFκB decoy oligonucleotides for arthritis as a gene therapy (2001) (0)
Transfection of Heat-Shock Protein 70 Enhances Myocardial Tolerance to Ischemia: Evidence for a Role of HSP70 in Ischemia-Reperfusion Injury (1998) (0)
Recovery of Learning and Memory by Gene Therapy Using Hepatocyte Growth Factor Gene After Focal Cerebral Ishcemia in Rats(Gene Therapy/Genetic Engineering (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation (2002) (0)
Cut-C: cleavage under tethered nuclease for conformational capture (2019) (0)
localization of gene expression Gene transfer to vein graft wall by HVJ-liposome method: time course and (2013) (0)
INCREASE IN DNA SYNTHESIS OF CARDIAC MYOCYTES BYTRANSFECTION OF ANTISENSE P53 AND RB OLIGODEOXYNUCLEOTIDES(ODN);POSSIBILITY OF REGENERATION OF CARDIAC MYOCYTES: P 49 (2004) (0)
216. Enhancement of Gene Transfection Both In Vitro and In Vivo Using Polymer Conjugated HVJ-Envelope Vector (2005) (0)
Overexpression of HGF (Hepatocyte Growth Factor) Reduced Ischemic Injury in Rat Permanent Middle Cerebral Artery Occlusion (MCAO) Model (2003) (0)
Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes (2001) (0)
Gene Therapy for Myocardial Infarction (1998) (0)
In vitro investigation for high efficiency PPIX-PDT with nonviral vector, HVJ-E (2011) (0)
Gene Therapy for Abdominal Aortic Aneurysm (AAA) using Decoy Strategy against ets binding site (2002) (0)
Deterioration in the ischemic damage of hippocampal CA1 neurons by intraventricular administration of antisense DNA against synapsin I (1998) (0)
Constructing a complete restriction map of human chromosome 19. (1988) (0)
-0057-DETERMINATIONS OF THE GENETIC DISORDERS OF FABRY'S DISEASE (1990) (0)
Pharmacological activity of NF-κB decoy (II). Effect of NF-κB decoy on Colon26-induced cachexia in mice. (1996) (0)
Author Correction: Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens (2021) (0)
Gene Through Induction of Apoptosis Inhibition of Growth of Human Vascular Smooth Muscle Cells by Overexpression of p21 (2013) (0)
Potential gene therapy using e2f decoy approach with hvj-liposome method to glomerulonephritis in rats (1996) (0)
Tokuda Akihiro Tomida Shinya Toyokuni Hitoshi Tsuda Shoichiro Tsugane Tatsuhiko Tsunoda Heiichiro Udono Koji Ueda Yoshimasa Uehara Hiroo Ueno Kazuo Umezawa Toshikazu Ushijima Toshihiko Wakabayashi Kenji Wakai Tetsuro Watabe (2016) (0)
Development of Novel High Throughput Functional Screening System Based on HVJ-E Vector : Screening of Anti-vascular Remodeling Factor in Hypertension(Hypertension, Basic 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Multi-modal Anti-cancer Activities Provided by a Non-replicating Sendai Virus Envelope (2015) (0)
IS026 Hypoxia Induced Endothelial Apoptosis Through the Activation of NFkB : In Vivo Evidence of Importance of NFkb in Endothelial Cell Regulation (2000) (0)
PD32-04 PHASE I/II CLINICAL TRIAL TO ASSESS SAFETY AND EFFICACY OF INTRATUMORAL AND SUBCUTANEOUS INJECTION OF HVJ-E TO CASTRATION RESISTANT PROSTATE CANCER PATIENTS (2016) (0)
MP66-01 GENE KNOCKOUT OF NANOG AND NANOGP8 MEDIATED BY CRISPR/CAS9 DECREASES THE MALIGNANT POTENTIAL OF PROSTATE CANCER CELLS. (2016) (0)
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells (2018) (0)
Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF (2002) (0)
Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis (1999) (0)
P 202 Title: Efficient and noninvasive in vivo gene transfer technique into adult mammalian ocular tissue (1995) (0)
Novel Therapeutic Strategy for Restenosis Using Ribozyme Oligonucleotides Against Transforming Growth Factor-β (2000) (0)
S1102 Development of gene delivery system for future gene therapy (2002) (0)
Chimeric Gene Delivery Systems (2003) (0)
CROSS-TALK BETWEEN BONE MARROW AND TISSUE INJURY: NOVEL REGENERATIVE THERAPY FOR SEVERELY DAMAGED TISSUES BY MOBILIZING BONE MARROW MESENCHYMAL STEM CELLS IN VIVO (2013) (0)
Therapeutic effect of hepatocyte growth factor in TNBS induced colitis (2000) (0)
P336: Alpha-synuclein, causative molecule of Parkinson’s disease, plays significant pathophysiological roles in aging-related metabolic syndrome (2014) (0)
Angiogenesis induced by human hepatocyte growth factor gene without nitric oxide synthesis in a rat ischemic hindlimb model (2003) (0)
Subcellular localization of novel photosensitizer named porphyrus envelope in human prostate cancer cell line PC-3 (2017) (0)
Heat Shock Protein 70-Induced Cardioprotection Involves Preservation of Manganese Superoxide Disumutase Activity, Associated with Mitochondria! Protection and Apoptosis Reduction (2003) (0)
OE-185 Topical application of novel angiogenic peptide, AG-30, in wound healing model(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
NOVEL PATHOPHYSIOLOGICAL ROLES OF ALPHA-SYNUCLEIN (SNCA) IN AGE-RELATED VASCULAR ENDOTHELIAL DYSFUNCTION (2021) (0)
Cancer Therapy : Preclinical Systemic Administration of a Novel Immune-Stimulatory Pseudovirion Suppresses Lung Metastatic Melanoma by Regionally Enhancing IFN-g Production (2013) (0)
329 Subcutaneous transplantation of allogenic mesenchymal stromal cells ameliorates intractable ulcers in recessive dystrophic epidermolysis bullosa patients (2017) (0)
[Strategies for gene therapy]. (2005) (0)
Evaluation of therapeutic efficacy induced by a novel photosensitizer : talaporfin sodium-incorporated viral particle (光・レーザーの医学・医療応用) (2017) (0)
Development of Laser Ionization Imaging Mass Spectrometry for Multiple Drugs Administered to Cancer Cells (2015) (0)
In vivo Gene Transfer for the Therapy of Vascular Diseases (1995) (0)
Novel molecular intervention to treat abdominal aortic aneurysms (AAA) using chimera decoy oligodeoxynucleotides (ODN) against ets and NFkB binding sites (2002) (0)
949 Single cell RNA-seq and single cell ATAC-seq analyses during a treatment for dystrophic epidermolysis bullosa (2019) (0)
Favorable effects of statins beyond lipid lowering (2006) (0)
Usage of reprication-eficient viral particle for photodynamic therapy against prostate cancer allows high cytotoxicity through different pathways (2017) (0)
Erratum: Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes (Journal of Drug Targeting vol. 8 (4) (207-216)) (2001) (0)
DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression (2022) (0)
Abstract 2911: Gene knockout of NANOG and NANOGP8 mediated by CRISPR/Cas9 system decreases the malignant potential of prostate cancer cells (2016) (0)
Tools for efficient gene delivery and expression (2016) (0)
Signal Transduction Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR 4 , ERK 1 / 2 and c-Myc (2013) (0)
297. Development of HVJ-E High Throughput Gene Function Screening System: Screening of Endothelial Cell Growth Factors (2004) (0)
Microbubble and ultrasound enhanced gene delivery for melanoma in vitro and in vivo. (2004) (0)
A histologically distinctive interstitial pneumoniainduced by overexpression oftheinterleukin 6,transforming growthfactor 131, orplatelet-derived growth factor Bgene (invivo transfection/hemagglutinating virus ofJapan-liposome/adenovirus vector) (1995) (0)
653. Systemic High Mobility Group Box 1 Administration Suppresses Skin Inflammation By Inducing Accumulation of PDGFRα+ Mesenchymal Cells from Bone Marrow (2015) (0)
Dual function of SF3B2 on chromatin and RNA to regulate transcription in head and neck squamous cell carcinoma (2022) (0)
CLINICAL RESULTS OF TREAT-HGF (JAPAN TRIAL TO TREAT PERIPHERAL ARTERIAL DISEASE BY THERAPEUTIC ANGIOGENESIS USING HEPATOCYTE GROWTH FACTOR GENE TRANSFER): P 531 (2003) (0)
Abstract 1351: Ubiquitin Carboxyl-Terminal Esterase L1, Causative Gene of Parkinson's Disease, Modulates Anti-Inflammatory-Mediated Vascular Remodeling (2006) (0)
Vaccin d'arn contre le cancer et ses procedes de mise en application (1999) (0)
452. Bone Marrow Stem Cells Are Potent Targets for Gene Therapy of Epidermolysis Bullosa, a Genetic Blistering Skin Disease (2006) (0)
HMGB1 accelerates skin regeneration by inducing bone marrow mesenchymal stromal cells (2016) (0)
Transforming growth factor-b 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction (2015) (0)
Increase in DNA Synthesis of Cardiac Myocytes by Transfection ofP53 and Rb Antisense : Possibility of Cardiac Myocytes Regeneration (2003) (0)
PS-B12-12: NOVEL PATHOPHYSIOLOGICAL ROLES OF A-SYNUCLEIN IN AGE-RELATED VASCULAR ENDOTHELIAL DYSFUNCTION AND E NHANCED PERMEABILITY. (2023) (0)
RETROGRADE GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR INTO RAT NERVOUS SYSTEM USING NONVIRAL HVJ-LIPOSOME METHOD: NOVEL THERAPEUTIC STRATEGY FOR CRUSHED NERVE (2006) (0)
The Role of Hepatocyte Growth Factor (HGF) in Vasculogenesis and Angiogenesis in Xenopus Development (2003) (0)
Novel vaccination (HVJ-liposome/HSP65 DNA+ IL-12 DNA against Tuberculosis) (47.15) (2007) (0)
Gene Transfer by HVJ-liposome. (1998) (0)
The 15th Annual Meeting 2009 Japan Society of Gene Therapy (2010) (0)
Analysis of antitumor immunity of HVJ-E (hemagglutinating virus of Japan envelope) and development in its clinical application for advanced malignant melanoma patients (2009) (0)
191. Improvement of Myocardial Dysfunction by Therapeutic Angiogenesis Induced by Transfection of HGF Gene Using Left Ventricular Electromechanical Mapping in Porcine Chronic Myocardial Infarction Model (2004) (0)
Co-Transfection of Human Hepatocyte Growth Factor and Prostacyclin Synthase Gene Enhanced Therapeutic Angiogenesis in Rat and Rabbit Ischemia Model (2003) (0)
[Gene therapy for colorectal cancer in clinical trials]. (2003) (0)
Decoy strategy for joint destruction of arthritis (1999) (0)
Medicines for hörfunk functional disorders (2003) (0)
Polymorphism of myospryn is associated with left ventricular diastolic dysfunction (2008) (0)
Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease (2003) (0)
Tools for efficient transfection in immune cells (2017) (0)
1119. Isolation of a Novel Therapeutic Angiogenic Peptide, AG-30, by High Throughput Screening Using the HVJ-E Vector (2005) (0)
OJ-195 Pivotal Roles of Deubiquitinating Enzymes UCHL1, HAUSP, and CYLD in Vasculature as an Anti-proliferative and Anti-inflammatory Effect(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
The cells from the patients of tuberous sclerosis lost the nuclear antigen detected by anti-chromosomal monoclonal anylbody M108 (1993) (0)
149. In Vitro-Synthesized Sendai Virus RNA Fragments Induced Antitumor Immunity and Cancer Cell-Selective Apoptosis (2016) (0)
GENE THERAPY FOR ATTENUATING CARDIAC ALLOGRAFT ARTERIOSCLEROSIS USING EX VIVO ANTISENSE PROLIFERATING‐CELL NUCLEAR ANTIGEN OLIGONUCLEOTIDE TRANSFECTION BY HVJ‐LIPOSOME METHOD.: Abstract# 929 Poster Board #‐Session: P186‐III (2000) (0)
Vascular Specific Organogenesis from Embryonic Stem Cells on Three Dimensional Layer of Matrigel (2003) (0)
Angiogenesis induced by hepatocyte growth factor (HGF) : The possibility of gene therapy for ischemic heart diseases (1999) (0)
Gene therapy for preventing delayed neuronal death using hepatocyte growth factor (2002) (0)
Abstract 5094: OSBPL10 is Identified as a Novel Susceptible Gene for Peripheral Arterial Disease by Genome-Wide Association Study in Japan (2008) (0)
Preliminary clinical results from TREAT-HGF : Gene therapy for PAD (2002) (0)
Modification of plasmid DNA-based gene transfer into central nerve system (2004) (0)
992. Induction of Immune Tolerance to Transgene Products by Mixed Chimerism with Low Dose Irradiation (2006) (0)
873. Development of High Throughput Functional Screening of Cardiovascular Therapeutic Genes Using the HVJ-E Vector (2006) (0)
Topical application of the NF-kB-dummies for the treatment of atopic dermatitis (2002) (0)
Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF) (2003) (0)
Correction to: Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium (2020) (0)
Gene Therapy of Cardiovascular diseases by protein-modified liposomes (1997) (0)
The role of oxidative stress in apoptosis of endothelial cells (2000) (0)
[Development of viral envelope-based drug delivery vectors]. (2007) (0)
Immunity to mycobacterial infection (PP-061) (2010) (0)
A New Approach to Castration-Resistant Prostate Cancer Using Inactivated Virus (2018) (0)
No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF (2002) (0)
BETA-ADRENERGIC AGONIST NORMAL RAT HEART ENHANCES CARDIAC RESPONSE TO GENE TRANSFECTION OF BETA 2-ADRENERGIC RECEPTOR INTO THE (2010) (0)
Dual function of SF3B2 on chromatin and RNA to regulate transcription in head and neck squamous cell carcinoma (2022) (0)
[Current status and future prospective of gene therapy]. (2005) (0)
Crosstalk mechanism between injured epithelia and bone marrow (2012) (0)
Hypertensive RatsProduced byInVivo Introduction oftheHumanReninGene (1993) (0)
ERADICATION OF RENAL CELL CARCINOMA IN MICE, MEDIATED BY NK CELL INFILTRATION AND ACTIVATION USING INACTIVATED SENDAI VIRUS PARTICLE (2008) (0)
Abstract 899: FHL-2 Suppresses VEGF-induced Angiogenesis via Sphingosine Kinase-1 (2007) (0)
IS049 APOPTOSIS MEDIATED BY P53 THROUGH BAX PATHWAY IN HUMAN AORTIC VASCULAR SMOOTH MUSCLE CELLS (1997) (0)
579 Single cell transcriptome and epigenome analyses in a murine model of dystrophic epidermolysis bullosa (2019) (0)
Effective Photodynamic Therapy to Drug-Resistant Prostate Cancer Cells Utilizing Non-Viral Antitumor Vector (2015) (0)
Histological Changes of Feline Mammary Carcinoma Treated by NPe6 HVJ-E PDT (2020) (0)
626. Inactivated Sendai Virus Particle (HVJ-E) Solely Induces Specific Anti-Tumor Immune Response and Eradicates Murine Carcinoma (2006) (0)
Selective and facilitated delivery of antisense oligonucleotides into primate trabecular meshwork cells by liposomes coated with the envelope of hemagglutinating virus of Japan (1996) (0)
Development of Protein-Liposome Gene Delivery System and Its Application for the Treatment of Acquired Diseases (1996) (0)
Necessary for Correct Hematopoietic and B Cell Development Graphical Abstract Highlights (2017) (0)
Present and Future in the gene therapy for cardiovascnlar disease (1999) (0)
Cold shock domain protein A, novel endogenous regulator of angiogenesis in heart (2008) (0)
Viral liposomes. Preparation and use. (2002) (0)
Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA) (2003) (0)
Liposome-mediated in vivo transfer of LacZ gene and antisense oligonucleotides into mammalian retina using the envelope of hemagglutinating virus of Japan (1996) (0)
COEXPRESSION OF FAS LIGAND AND BCL-2 IN RAT LIVER TRANSPLANTATION (1999) (0)
517. Prevention of Onset of Parkinson's Disease by In Vivo Gene Transfer of Human Hepatocyte Growth Factor in Primate Model: A Model of Gene Therapy for Parkinson's Disease (2004) (0)
Evaluation of a novel photosensitizing drug having antitumor effect for advanced prostate cancer (2017) (0)
Improvement of Myocardial Dysfunction by Therapeutic Angiogenesis Induced by Transfection of HGF Gene in Porcine Chronic Myocardial Ischemia Model(Gene Therapy 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer) (2002) (0)
[DNA methylation and chromatin modification on transcription]. (2000) (0)
391. De Novo Human Artificial Chromosome Formation Is Predetermined by Initial Chromatin Assembly and Transcriptional Patterns after Transfection (2006) (0)
Introduction of Plasmid DNA and Oligonucleotides into Lung Epithelial Cells by the Hemagglutinating Virus of Japan (HVJ)-Liposome Method (1999) (0)
1043 Systemic delivery of HMGB1 peptide ameliorates imiquimod-induced psoriasis-like dermatitis (2018) (0)
Therapeutic Angiogenesis Induced by Endotherial Nitric Oxide Synthase Gene through VEGF Expression in Rat Hindlimb Ischemia Model (2003) (0)
[Gene therapy for attenuating chronic rejection of cardiac allografts]. (1999) (0)
The reduction of chromosomal protein P40 in tuberous sclerosis (1994) (0)
[Current status of gene therapy in Japan and other countries]. (2010) (0)
Development of New Technologies to Establish Organ Transplantation of the Next Era (2003) (0)
OE-040 FHL-2 Expresses in Endothelial Cell and Suppresses VEGF-induced Angiogenesis Via Sphingosine Kinase-1(Arrhythmia, diagnosis/Pathophysiology/EPS(01)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
Abstract 4359: TRAIL and Noxa are selectively up-regulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by non-replicating Sendai virus particles. (2013) (0)
Abstract 5399: Mechanism of efficient eradication of castration-resistant human prostate cancer cells by inactivated Sendai virus particle (2011) (0)
Transcription factor, ets-1, is a novel angiogenic molecule : Implication to ciene therapy to treat peripheral arterial disease (2002) (0)
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. (2012) (0)
Development of Cationic Liposomes Conjugated with HVJ and Immunoliposomes with anti-Thy-1 Antibody (2003) (0)
Development of transferrin receptor-targeting Sendai virus (2006) (0)
PE-275 A Novel Strategy of the Gene Therapy for PAD Using Small RNA Interference of Cold Shock Domain Protein A(PE046,Atherosclerosis (Basic, Clinical/Diagnosis) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
Gene therapy strategy of glomerulosclerosis. (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yasufumi Kaneda?

Yasufumi Kaneda is affiliated with the following schools:

Osaka University

Yasufumi Kaneda's Academic­Influence.com Rankings

Yasufumi Kaneda's Degrees

Why Is Yasufumi Kaneda Influential?

Yasufumi Kaneda's Published Works

Published Works

What Schools Are Affiliated With Yasufumi Kaneda?

Yasufumi Kaneda's AcademicInfluence.com Rankings